Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Tralokinumab> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- Tralokinumab abstract "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology as CAT-354 who took it through pre-clinical development. As of April 2012 it is being developed by MedImmune.".
- Tralokinumab atcPrefix "none".
- Tralokinumab casNumber "1044515-88-9".
- Tralokinumab wikiPageID "33024164".
- Tralokinumab wikiPageRevisionID "601070887".
- Tralokinumab atcPrefix "none".
- Tralokinumab c "6374".
- Tralokinumab casNumber "1044515".
- Tralokinumab chemspiderid "NA".
- Tralokinumab h "9822".
- Tralokinumab hasPhotoCollection Tralokinumab.
- Tralokinumab mabType "mab".
- Tralokinumab molecularWeight "143.87".
- Tralokinumab n "1698".
- Tralokinumab o "2014".
- Tralokinumab s "44".
- Tralokinumab source "u".
- Tralokinumab target Interleukin_13.
- Tralokinumab type "mab".
- Tralokinumab verifiedfields "changed".
- Tralokinumab verifiedrevid "470612083".
- Tralokinumab subject Category:Monoclonal_antibodies.
- Tralokinumab type Abstraction100002137.
- Tralokinumab type Antibody115027189.
- Tralokinumab type Chemical114806838.
- Tralokinumab type Compound114818238.
- Tralokinumab type Macromolecule114944888.
- Tralokinumab type Material114580897.
- Tralokinumab type Matter100020827.
- Tralokinumab type Molecule114682133.
- Tralokinumab type MonoclonalAntibodies.
- Tralokinumab type MonoclonalAntibody115029781.
- Tralokinumab type OrganicCompound114727670.
- Tralokinumab type Part113809207.
- Tralokinumab type PhysicalEntity100001930.
- Tralokinumab type Protein114728724.
- Tralokinumab type Relation100031921.
- Tralokinumab type Substance100019613.
- Tralokinumab type Thing100002452.
- Tralokinumab type Unit109465459.
- Tralokinumab type Drug.
- Tralokinumab type FunctionalSubstance.
- Tralokinumab comment "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology as CAT-354 who took it through pre-clinical development. As of April 2012 it is being developed by MedImmune.".
- Tralokinumab label "Tralokinumab".
- Tralokinumab sameAs m.0h53vbn.
- Tralokinumab sameAs Q7833105.
- Tralokinumab sameAs Q7833105.
- Tralokinumab sameAs Tralokinumab.
- Tralokinumab wasDerivedFrom Tralokinumab?oldid=601070887.
- Tralokinumab isPrimaryTopicOf Tralokinumab.